Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke "DATAS"


Phase 2 Results N/A

Summary of Purpose

Objective: Demonstrate the safety of early use of dabigatran following TIA/minor stroke. Background: Although aggressive antithrombotic therapy has been shown to reduce the number of new ischemic events following stroke/TIA, this has always been offset by an increase in the risk of hemorrhagic transformation. Dabigatran is much safer than previously tested antithrombotic agents, with respect to intracranial...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 October 2014.

1 Feb 2012 24 Feb 2012 1 May 2014 1 May 2014 1 Oct 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


  • Ken S Butcher, MD,PhD